Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Vertex Pharmaceuticals (GB:0QZU)
LSE:0QZU
Vertex Pharmaceuticals (GB:0QZU) Stock Price & Analysis
3 Followers
0QZU Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$225.55 - $324.01
Previous Close$313.09
Volume730.00
Average Volume (3M)4.25K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$9.77B
Total Debt (Recent Filing)$824.60M
Price to Earnings (P/E)24.7
Beta0.15
Next EarningsFeb 07, 2023
EPS Estimate$3.53
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$326.88
EPS (TTM)12.67
Shares Outstanding256,691,452
R-Squared0.05
Standard Deviation0.08
10 Day Avg. Volume752
30 Day Avg. Volume4,250
Price to Book (P/B)6.96
Price to Sales (P/S)8.99
Price to Cash Flow (P/CF)19.70
P/FCF Ratio30.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside4.40% Upside
Rating ConsensusModerate Buy
Alpha0.01
Number of Analyst Covering18
Vertex Pharmaceuticals News
0QZU FAQ
What was Vertex Pharmaceuticals’s price range in the past 12 months?
Vertex Pharmaceuticals lowest stock price was $225.55 and its highest was $324.00 in the past 12 months.
What is Vertex Pharmaceuticals’s market cap?
Currently, no data Available
When is Vertex Pharmaceuticals’s upcoming earnings report date?
Vertex Pharmaceuticals’s upcoming earnings report date is Feb 07, 2023 which is in 11 days.
How were Vertex Pharmaceuticals’s earnings last quarter?
Vertex Pharmaceuticals released its earnings results on Oct 27, 2022. The company reported $4.01 earnings per share for the quarter, beating the consensus estimate of $3.613 by $0.397.
Is Vertex Pharmaceuticals overvalued?
According to Wall Street analysts Vertex Pharmaceuticals’s price is currently Undervalued.
Does Vertex Pharmaceuticals pay dividends?
Vertex Pharmaceuticals does not currently pay dividends.
What is Vertex Pharmaceuticals’s EPS estimate?
Vertex Pharmaceuticals’s EPS estimate is $3.53.
How many shares outstanding does Vertex Pharmaceuticals have?
Vertex Pharmaceuticals has 256,691,440 shares outstanding.
What happened to Vertex Pharmaceuticals’s price movement after its last earnings report?
Vertex Pharmaceuticals reported an EPS of $4.01 in its last earnings report, beating expectations of $3.613. Following the earnings report the stock price went up 6.267%.
Which hedge fund is a major shareholder of Vertex Pharmaceuticals?
Among the largest hedge funds holding Vertex Pharmaceuticals’s share is Bridgewater Associates, LP. It holds Vertex Pharmaceuticals’s shares valued at 47M.
---
Vertex Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$326.88
$326.88
Blogger Sentiment
Bullish
GB:0QZU Sentiment 95%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.82%
12-Months-Change
Fundamentals
Return on Equity
29.02%
Trailing 12-Months
Asset Growth
32.39%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Vertex Pharmaceuticals
Based in Massachusetts and incorporated in 1989, Vertex Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.
---
---